BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29630366)

  • 1. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
    García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
    J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε.
    Bischof J; Leban J; Zaja M; Grothey A; Radunsky B; Othersen O; Strobl S; Vitt D; Knippschild U
    Amino Acids; 2012 Oct; 43(4):1577-91. PubMed ID: 22331384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
    Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(1H-Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1δ/ε inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Karthikeyan C; Jharia P; Waiker DK; Nusbaum AC; Amawi H; Kirwen EM; Christman R; Arudra SKC; Meijer L; Tiwari AK; Trivedi P
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2663-2667. PubMed ID: 28487075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the potent and selective inhibition of casein kinase 1 epsilon.
    Long AM; Zhao H; Huang X
    J Med Chem; 2012 Nov; 55(22):10307-11. PubMed ID: 23106386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.
    Yuan F; Li D; Guo M; Fang T; Sun J; Qi F; Rao Q; Zhao Z; Huang P; Yang B; Xia J
    Biochem Biophys Res Commun; 2020 Mar; 523(3):809-815. PubMed ID: 31954519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor.
    Long A; Zhao H; Huang X
    J Med Chem; 2012 Jan; 55(2):956-60. PubMed ID: 22168824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
    Cheong JK; Nguyen TH; Wang H; Tan P; Voorhoeve PM; Lee SH; Virshup DM
    Oncogene; 2011 Jun; 30(22):2558-69. PubMed ID: 21258417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1δ and ε with nanomolar inhibitory activity on cancer cell proliferation.
    Richter J; Bischof J; Zaja M; Kohlhof H; Othersen O; Vitt D; Alscher V; Pospiech I; García-Reyes B; Berg S; Leban J; Knippschild U
    J Med Chem; 2014 Oct; 57(19):7933-46. PubMed ID: 25191940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth.
    Greer YE; Rubin JS
    J Cell Biol; 2011 Mar; 192(6):993-1004. PubMed ID: 21422228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.
    Monastyrskyi A; Nilchan N; Quereda V; Noguchi Y; Ruiz C; Grant W; Cameron M; Duckett D; Roush W
    Bioorg Med Chem; 2018 Feb; 26(3):590-602. PubMed ID: 29289448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
    Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.
    Janovska P; Verner J; Kohoutek J; Bryjova L; Gregorova M; Dzimkova M; Skabrahova H; Radaszkiewicz T; Ovesna P; Vondalova Blanarova O; Nemcova T; Hoferova Z; Vasickova K; Smyckova L; Egle A; Pavlova S; Poppova L; Plevova K; Pospisilova S; Bryja V
    Blood; 2018 Mar; 131(11):1206-1218. PubMed ID: 29317454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.
    Peifer C; Abadleh M; Bischof J; Hauser D; Schattel V; Hirner H; Knippschild U; Laufer S
    J Med Chem; 2009 Dec; 52(23):7618-30. PubMed ID: 19591487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
    Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
    Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes.
    Meng QJ; Maywood ES; Bechtold DA; Lu WQ; Li J; Gibbs JE; Dupré SM; Chesham JE; Rajamohan F; Knafels J; Sneed B; Zawadzke LE; Ohren JF; Walton KM; Wager TT; Hastings MH; Loudon AS
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15240-5. PubMed ID: 20696890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems.
    Grieco I; Bissaro M; Tiz DB; Perez DI; Perez C; Martinez A; Redenti S; Mariotto E; Bortolozzi R; Viola G; Cozza G; Spalluto G; Moro S; Federico S
    Eur J Med Chem; 2021 Apr; 216():113331. PubMed ID: 33721670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor promoter TPA activates Wnt/β-catenin signaling in a casein kinase 1-dependent manner.
    Su Z; Song J; Wang Z; Zhou L; Xia Y; Yu S; Sun Q; Liu SS; Zhao L; Li S; Wei L; Carson DA; Lu D
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7522-E7531. PubMed ID: 30038030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for the regulation of the circadian clock kinases CK1δ and CK1ε.
    Yang Y; Xu T; Zhang Y; Qin X
    Cell Signal; 2017 Feb; 31():58-65. PubMed ID: 28057520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casein kinase 1δ activity: a key element in the zebrafish circadian timing system.
    Smadja Storz S; Tovin A; Mracek P; Alon S; Foulkes NS; Gothilf Y
    PLoS One; 2013; 8(1):e54189. PubMed ID: 23349822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.